总时间（秒）：16.42
问答时间（秒）：16.31

```json
{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_000310.4:c.1869G>A",
          "cDNA Change": {
            "transcript": "NM_000310.4",
            "ref": "G",
            "alt": "A",
            "position": "1869"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "623"
          },
          "Description in input context": "This variant disrupts the highly conserved RPR motif."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0003396"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunofluorescence",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y cells",
        "Description": "Experiments were performed using SH-SY5Y cells transfected with wild type or mutant PARK2 cDNA."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000310.4:c.1869G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Immunofluorescence staining revealed a marked reduction in PARKIN protein levels in cells harboring the NM_000310.4:c.1869G>A variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Images were acquired in triplicate for each condition."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Cells transfected with wild-type PARK2 cDNA served as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Cells transfected with an empty vector served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": null
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": null
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "PARKIN protein level comparable to control cells. Subjective assessment based on intensity of staining.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant reduction in PARKIN protein levels compared to control cells. Subjective assessment based on intensity of staining.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```